Figure 1.

Post-vaccinated anti-viral antibody responses of pemphigus patients or healthy controls. (A) Post-vaccinated anti-viral antibody responses after the second vaccination, or (B) the third vaccination; (C) The differences in anti-viral antibody titers after receiving the second or third vaccination between the patients and the healthy controls; (D) Longitudinal follow-up of post-vaccination anti-viral antibody responses to the second and the third vaccination of pemphigus patients; (E) The influence of peripheral B-cell deficiency on post-vaccination anti-viral antibody responses after the second dose, and (F) the third dose. Data are presented as the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, calculated by 2-tailed two-sample t-test, unpaired t-test with Welch’s correction, or paired sample t-test as appropriate.